top of page
Search

Calcalist - RespirAI prepares to set the “smoker’s disease” alight with new digital health platform

  • RespirAI
  • Apr 7, 2024
  • 1 min read

Updated: 1 day ago

The company has raised a total of $1.1 million to provide real-time monitoring and personalized insights for respiratory conditions such as COPD

RespirAI first clinical trial results were presented at the Israeli Society of Pulmonology meeting
Ophir Shahaf, eHealth Ventures; Nimrod Bin-Nun and Assaf Gur, RespirAI; Talor Sax, eHealth Ventures (Photo: EHV)

bottom of page